文献速递胸部肿瘤

ctDNA检测肺癌微小残留病灶:当前证据与未来方向

Detection of Minimal Residual Disease Using ctDNA in Lung Cancer: Current Evidence and Future Directions.
PubMed 文献 · J Thorac Oncol · 2018-10-06

综述探讨了ctDNA用于肺癌术后微小残留病灶(MRD)检测的现有证据,指出ctDNA可无创、纵向评估,有望识别复发高风险患者并指导辅助治疗决策,但需进一步验证。

要点

  • ctDNA可无创获取并纵向监测,用于检测肺癌术后MRD。
  • MRD检测有望识别复发高风险患者,指导辅助治疗。
  • 现有证据支持ctDNA用于MRD评估,但需前瞻性验证。

核心结论

  • ctDNA分析用于检测肺癌术后MRD具有潜在临床价值,可帮助识别复发风险增加的患者并指导可切除肺癌的治疗决策。

研究设计与样本

  • 综述总结了ctDNA分析方法的现状,并评估了支持使用ctDNA分析评估MRD的证据。

主要发现

  • 多项研究提示ctDNA可用于检测包括肺癌在内的多种癌症手术切除后的MRD。
  • ctDNA可无创获取,允许随时间进行系列评估。

临床怎么用

  • MRD检测可能帮助识别复发风险增加的可切除肺癌患者,从而指导辅助治疗决策。

局限性

  • 需进一步验证此类方法并扩大这些快速进展技术的效用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Advances in DNA sequencing methods have significantly expanded the potential clinical applications of analyzing circulating tumor DNA (ctDNA). This genetic information can identify the presence of targetable mutations and has been explored for cancer screening purposes. ctDNA can be obtained without the risks inherent to biopsy, allowing for serial assessments over time. Several studies have additionally suggested that ctDNA can be used to detect the presence of minimal residual disease (MRD) after surgical resection in several cancer types, including lung cancer. The ability to detect MRD would allow clinicians to tailor adjuvant therapies, which carry risks of significant toxicities and may benefit only select groups of patients. Here, we review the current state of ctDNA profiling methods and evaluate the evidence supporting the use of ctDNA analysis to assess for MRD. We discuss how MRD detection could help identify patients at increased risk of disease recurrence and thus guide treatment decisions for resectable lung cancer. Finally, we propose future steps to validate such approaches and expand the utility of these rapidly progressing technologies.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Chae YK, Oh MS. Detection of Minimal Residual Disease Using ctDNA in Lung Cancer: Current Evidence and Future Directions. J Thorac Oncol. 2018. PMID: 30296486. doi:10.1016/j.jtho.2018.09.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。